Skip to main navigation Skip to search Skip to main content

Malignant deep brain stimulator withdrawal syndrome

  • Jehad Azar*
  • , Hila Elinav
  • , Rifaat Safadi
  • , Mona Soliman
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Parkinsonism-hyperpyrexia syndrome (PHS) is a neurologic potentially fatal emergency that mimics neuroleptic malignant syndrome. It commonly presents as systemic inflammatory response syndrome, acute onset worsening of muscular rigidity, autonomic instability, hyperpyrexia, confusion, diaphoresis and high creatine phosphokinase. The most common trigger for PHS is reduction or withdrawal of anti-Parkinson's medications, especially levodopa. It was also reported in a few cases following deep brain stimulation of the subthalamic nucleus surgery shortly after anti-Parkinson's medications were discontinued. Rare causes of PHS include deep brain stimulator (DBS) malfunction due to battery depletion. To the best of our knowledge, PHS following DBS battery depletion was reported only in three occasions. Here, we report a case of PHS due to DBS battery depletion presented as sepsis and was successfully treated with the administration of dopamine agonists, intravenous fluids and changing the DBS battery.

Original languageEnglish
Article numbere229122
JournalBMJ Case Reports
Volume12
Issue number5
DOIs
StatePublished - 1 May 2019
Externally publishedYes

Bibliographical note

Publisher Copyright:
© BMJ Publishing Group Limited 2019.

Keywords

  • neuroendocrinology
  • neurology (drugs and medicines)

Fingerprint

Dive into the research topics of 'Malignant deep brain stimulator withdrawal syndrome'. Together they form a unique fingerprint.

Cite this